Osaic Holdings
BCTXW

Osaic Holdings’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Osaic Holdings’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-800
Closed -$72 – 7748
2025
Q1 		$72 Hold
800
– – ﹤0.01% 7264
2024
Q4 		$192 Hold
800
– – ﹤0.01% 7171
2024
Q3 		$328 Hold
800
– – ﹤0.01% 7088
2024
Q2 		$184 Hold
800
– – ﹤0.01% 7178
2024
Q1 		$1.04K Buy
+800
New +$1.34K ﹤0.01% 6677

Other funds holding BCTXW

RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings's BCTXW Position: Q2 2025 in Review

Osaic Holdings sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q2 2025, closing a stake of 800 shares — an estimated $72 sold.

Osaic Holdings first reported a position in BCTXW in Q1 2024 and held it in 5 quarters. The position peaked at $1.04K in Q1 2024. 6 funds tracked by Wall St. Rank hold BCTXW as of Q2 2025.

  • Osaic Holdings reported no remaining BriaCell Therapeutics Corp Warrant position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 800 BriaCell Therapeutics Corp Warrant shares in Q2 2025, an estimated $72.
  • Osaic Holdings first reported a position in BriaCell Therapeutics Corp Warrant in Q1 2024 and held it in 5 quarters.
  • Osaic Holdings's BriaCell Therapeutics Corp Warrant position peaked at $1.04K in Q1 2024.
  • 6 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.